Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
批准号:
10341851
负责人:
Amy M Pastva
金额:
$92.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-17 至 2026-08-31
关键词:
AccelerometerAddressAdherenceAdipose tissueAdultAgingAmericanApple watchAreaAwardBalance trainingBiological MarkersBone Marrow TransplantationCOVID-19COVID-19 pandemicCancer PatientCardiopulmonaryCaringCellular PhoneClinicClinical ResearchClinical TrialsClinical Trials DesignCognitionCognitive deficitsComputer softwareCritical CareCritical IllnessDataDevelopmentDevicesDiseaseDoseEducationElderlyEquilibriumExerciseExercise TestFundingFutureGlycogenGoalsHeart RateHomeHome environmentHospitalizationHospitalsImpairmentIndividualInflammationIntensive CareIntensive Care UnitsInterdisciplinary StudyInterval trainingInterventionIntramuscularKentuckyKnowledgeLeukocytesLiteratureMalignant NeoplasmsMeasuresMedical centerMedicineMental HealthMitochondriaMonitorMulticenter StudiesMulticenter TrialsMuscleMuscle functionMuscular AtrophyNear-Infrared SpectroscopyOhioOperative Surgical ProceduresOutcomeOutcomes ResearchOxygen ConsumptionPatient Self-ReportPatientsPerformancePersonsPhasePhysical ExercisePhysical FunctionPhysical PerformancePhysical RehabilitationPhysiologicalPilot ProjectsPopulationPublic HealthQuality of lifeRandomizedRecoveryRehabilitation therapyReportingResearchResearch InstituteResistanceSocietiesStructureSurvivorsSyndromeTestingUltrasonographyUnited States National Institutes of HealthUniversitiesVideoconferencingWalkingbasebrain dysfunctioncardiorespiratory fitnesschemotherapydigitaldisabilityexercise capacityexercise interventionexercise prescriptionexercise trainingexperiencefitnessfunctional outcomesimprovedinnovationmHealthmitochondrial metabolismmuscle formmuscle strengthnovelnovel strategiesolder patientpandemic diseasepatient safetyphysically handicappedprimary endpointprogramsranpirnaserehabilitation researchrehabilitation strategyremote monitoringsafety and feasibilitysevere COVID-19strength trainingsurvivorship
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Severe disease from COVID-19 requires hospitalization in 20% of adults, with a third of those patients requiring
intensive care unit (ICU) treatment. While a growing number of patients are surviving COVID-19 critical illness,
like other ICU survivors, the majority will experience significant post-hospital disabilities in physical function and
exercise capacity, new-onset disability, muscle wasting/weakness, and new cognitive deficits. These difficulties,
which can persist for months to years post-ICU, are collectively known as post-intensive care syndrome (PICS)
and may be more severe in COVID-19 survivors. Despite literature demonstrating the benefit of physical
rehabilitation in COVID-19 and other ICU survivors, there are limited available options and data to support an
optimal post-hospital physical rehabilitation strategy. Combined with the difficulties of delivering rehabilitation in-
person after hospitalization during a pandemic, addressing this “rehabilitation pandemic” from COVID-19
represents an enormous public health challenge. Previous studies of home-based physical rehabilitation in ICU
survivors have utilized unsupervised exercise training without a personalized exercise prescription, and none
have done so while actively monitoring and targeting exercise via physiologic data such as heart rate or included
strength and balance training. In debilitated older patients, high intensity interval training (HIIT) is safe and
associated with significant improvements (in as little as two weeks) in cardiorespiratory fitness (CRF) that also
correlates with self-reported physical function and disability. We have evaluated this approach in a successful
NIH-funded phase 1 pilot study demonstrating safety and feasibility of HIIT in debilitated older adults with cancer.
Adherence to exercise was 117% (meaning patients exercised more than recommended 3 sessions/week),
compliance with heart rate goals was 98% (meaning patients were actually doing HIIT vs. less-intensive
exercise), and on average patients improved CRF, as measured by VO2peak on cardiopulmonary exercise
testing by 25%. The key to our approach is our mHealth platform, in which patients are given Apple Watches
and iPhones preloaded with our software allowing us to remotely download data after each exercise session to
provide personalized up-coaching via videoconferencing in home setting. As critical illness survivors, including
COVID-19 ICU survivors, have impaired CRF (similar to patients in pilot study) and other manifestations of PICS,
a similar monitored, personalized, structured, and progressive multi-domain physical rehabilitation intervention
has significant potential for improving recovery, but has not yet been studied in COVID-19 survivors. To address
this gap in knowledge, we will randomize 140 COVID-19 ICU survivors being discharged home to our REmotely
Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM-HIIT-Covid-
19) study to test the hypothesis that the REMM-HIIT exercise intervention, in contrast to exercise education alone, will
improve CRF and muscle strength/mass (Aim 1); improve physical function and quality of life (Aim 2); and improve
markers of mitochondrial function and inflammation (Aim 3) measured at 3-months after discharge.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
-
批准号:10490892
-
项目类别:
-
资助金额:$79.91万
-
财政年份:2021
-
负责人:Amy M Pastva
-
依托单位:
Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
-
批准号:10688052
-
项目类别:
-
资助金额:$78.97万
-
财政年份:2021
-
负责人:Amy M Pastva
-
依托单位:
The in vivo Role of Surfactant Protein A in Allergic Lung Disease
-
批准号:7919724
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:Amy M Pastva
-
依托单位:
The in vivo Role of Surfactant Protein A in Allergic Lung Disease
-
批准号:7643374
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2008
-
负责人:Amy M Pastva
-
依托单位:
The in vivo Role of Surfactant Protein A in Allergic Lung Disease
-
批准号:8073638
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2008
-
负责人:Amy M Pastva
-
依托单位:
The in vivo Role of Surfactant Protein A in Allergic Lung Disease
-
批准号:7849548
-
项目类别:
-
资助金额:$11.51万
-
财政年份:2008
-
负责人:Amy M Pastva
-
依托单位:
The in vivo Role of Surfactant Protein A in Allergic Lung Disease
-
批准号:7531313
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2008
-
负责人:Amy M Pastva
-
依托单位:
海外基金